Stock listing

Frankfurt:C6K0 Avalo Therapeutics, Inc. Aktie

German listing (Frankfurt) of Avalo Therapeutics, Inc. · home listing NASDAQ:AVTX

Follow Avalo Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · FWB:C6K0

€6.47 EUR +0.57 (+9.7%)

Close on Oct 30, 2026

Day range
€6.47 – €6.47 EUROct 30, 2026
Market cap
€347.0M EURAt the close on Oct 30, 2026 · price × 53.63M shares outstanding
Avalo Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AVTX · Home$7.32 USD+0.15 (+2.1%)1,618,540$7.13$7.46$7.00$7.17Close on Nov 2, 2026
Frankfurt:C6K0€6.47 EUR+0.57 (+9.7%)—€6.47€6.47€6.47€5.90Close on Oct 30, 2026
Ticker
Frankfurt:C6K0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Avalo Therapeutics (NASDAQ:AVTX) Q3 2024 Earnings Call

    Wed, Oct 30, 2024 · 9:00 AM ET

    Watch Transcript
  • Avalo Therapeutics (NASDAQ:AVTX) Q2 2024 Earnings Call

    Wed, Jul 31, 2024 · 9:00 AM ET

    Watch Transcript
  • Avalo Therapeutics (NASDAQ:AVTX) Q1 2024 Earnings Call

    Wed, May 01, 2024 · 9:00 AM ET

    Watch Transcript

Latest news

All Avalo Therapeutics, Inc. news

Decks

Avalo Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 88 in all · newest Nov 2, 2026 · oldest 2021
Calls
4 calls with a replay · 4 with a transcript · latest Oct 30, 2024
Decks
40 decks · latest August 2026

Where Avalo Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AVTX · Home listingNASDAQUnited StatesUSD
gettex:C6K0gettexGermanyEUR
BOATS:AVTXBOATSUnited StatesUSD
LS Exchange:A3E2FRLS ExchangeGermanyEUR
Lang & Schwarz:A3E2FRLang & SchwarzGermanyEUR
Frankfurt:C6K0 · This pageFrankfurtGermanyEUR
Tradegate:C6K0TradegateGermanyEUR
Dusseldorf:C6K0DusseldorfGermanyEUR
Munich:C6K0MunichGermanyEUR
Stuttgart:C6K0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Avalo Therapeutics, Inc.